TRexBio Announces a First Option Was Exercised by Partner under Immunology Discovery Collaboration
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan 3, 2024--
Source: eagletribune.com
Stay updated with breaking news from Deep Biology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan 3, 2024--
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
TRexBio has inked a multi-year research collaboration and licensing agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Cos. of Johnson & Johnson. The companies will use TRexBio’s platform to discover novel targets that address unmet needs in TRex’s core therapeutic area of immunology and inflammation.